- Home
- NVS vs ABT Comparison
NVS vs ABT Comparison
Compare NVS & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVS
- ABT
- Stock Information
- Founded
- NVS 1895
- ABT 1888
- Country
- NVS Switzerland
- ABT United States
- Employees
- NVS N/A
- ABT N/A
- Industry
- NVS Biotechnology: Pharmaceutical Preparations
- ABT Medical/Dental Instruments
- Sector
- NVS Health Care
- ABT Health Care
- Exchange
- NVS Nasdaq
- ABT Nasdaq
- Market Cap
- NVS 230.5B
- ABT 221.0B
- IPO Year
- NVS 1991
- ABT N/A
- Fundamental
- Price
- NVS $112.56
- ABT $130.82
- Analyst Decision
- NVS Hold
- ABT Buy
- Analyst Count
- NVS 6
- ABT 18
- Target Price
- NVS $123.67
- ABT $136.06
- AVG Volume (30 Days)
- NVS 2.5M
- ABT 7.4M
- Earning Date
- NVS 04-29-2025
- ABT 04-16-2025
- Dividend Yield
- NVS 2.91%
- ABT 1.80%
- EPS Growth
- NVS N/A
- ABT 134.36
- EPS
- NVS 5.87
- ABT 7.64
- Revenue
- NVS $51,722,000,000.00
- ABT $41,950,000,000.00
- Revenue This Year
- NVS $4.36
- ABT $6.72
- Revenue Next Year
- NVS $1.93
- ABT $7.45
- P/E Ratio
- NVS $19.18
- ABT $17.12
- Revenue Growth
- NVS 10.85
- ABT 4.59
- 52 Week Low
- NVS $92.35
- ABT $99.71
- 52 Week High
- NVS $120.92
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- NVS 57.67
- ABT 52.64
- Support Level
- NVS $108.65
- ABT $124.50
- Resistance Level
- NVS $112.24
- ABT $128.79
- Average True Range (ATR)
- NVS 1.44
- ABT 2.83
- MACD
- NVS -0.26
- ABT -0.20
- Stochastic Oscillator
- NVS 80.52
- ABT 50.32
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.